Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

psoriatic arthritis
News
Vaccination Recommendations for Patients Receiving Antipsoriatic Systemic Therapies
07/26/2024
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate the literature on vaccine efficacy and safety, using a modified Delphi process to generate 22 consensus-based recommendations for adults receiving systemic therapies for psoriasis.
Researchers aimed to evaluate...
07/26/2024
The Dermatologist
psoriasis
News
Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
07/26/2024
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from the British Association of Dermatologists Biologics and Immunomodulators Register, focusing on adults treated with biologics for plaque psoriasis.
Researchers utilized data from...
07/26/2024
The Dermatologist
psoriasis
News
Overlap Phenotype Between Psoriasis and Atopic Dermatitis
07/18/2024
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene expression profiles of lesional and non-lesional skin biopsy tissues and the proteomic profiles of blood samples.
Researchers compared the gene...
07/18/2024
The Dermatologist

Advertisement

psoriatic arthritis
News
Efficacy and Safety of Pharmacologic Treatment of Psoriatic Arthritis
07/12/2024
Researchers conducted a systematic literature review, examining conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs.
Researchers conducted a systematic literature review, examining conventional synthetic, biologic, and targeted synthetic disease-modifying antirheumatic drugs.
Researchers conducted a...
07/12/2024
The Dermatologist
vitiligo
News
Promising Patient Outcomes With Autologous Skin Cell Suspension Transplantation for Vitiligo
06/28/2024
A new study highlights the effectiveness of autologous skin cell suspension transplantation in treating stable vitiligo, showing positive patient-reported outcomes and significant repigmentation improvements.
A new study highlights the effectiveness of autologous skin cell suspension transplantation in treating stable vitiligo, showing positive patient-reported outcomes and significant repigmentation improvements.
A new study highlights the...
06/28/2024
The Dermatologist
vitiligo
News
Evaluating Efficacy of Ritlecitinib With or Without nbUVB in Treating Non-Segmental Vitiligo
06/28/2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, has shown promising results in the treatment of non-segmental vitiligo (NSV), according to a recent Phase 2b trial.
Ritlecitinib, a JAK3/TEC family kinase inhibitor, has shown promising results in the treatment of non-segmental vitiligo (NSV), according to a recent Phase 2b trial.
Ritlecitinib, a JAK3/TEC family...
06/28/2024
The Dermatologist

Advertisement

psoriasis
News
Diagnosis and Management of Nail Psoriasis and Nail Lichen Planus
06/26/2024
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how timely recognition of clinical signs and symptoms is crucial for initiating appropriate treatment and alleviating the associated disease burden.
Researchers aimed to review how...
06/26/2024
The Dermatologist
psoriatic arthritis
News
Global and Regional Epidemiology of Psoriatic Arthritis in Patients With Psoriasis
06/26/2024
Researchers comprehensively analyzed global epidemiologic data on psoriatic arthritis (PsA) among patients with psoriasis.
Researchers comprehensively analyzed global epidemiologic data on psoriatic arthritis (PsA) among patients with psoriasis.
Researchers comprehensively...
06/26/2024
The Dermatologist
cream
News
Local Tolerability of Topical Roflumilast Across Dermatologic Conditions in Phase 3 Trials
06/25/2024
Riya Gandhi, MA, Associate Editor
Topical roflumilast has demonstrated robust local tolerability profiles in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
Topical roflumilast has demonstrated robust local tolerability profiles in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
Topical roflumilast has...
06/25/2024
The Dermatologist

Advertisement

psoriasis
News
PF-07038124 in Treating Atopic Dermatitis and Plaque Psoriasis
06/24/2024
Riya Gandhi, MA, Associate Editor
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical trial PF-07038124, a topical phosphodiesterase 4 inhibitor, has shown significant promise in treating both atopic dermatitis and plaque psoriasis, 2 common inflammatory skin conditions known for their challenging...
In a recent phase 2a clinical...
06/24/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Cellulite System Gains FDA Clearance
08/28/2015
The Cellfina System (Ulthera Inc., a subsidiary of Merz, Inc. and a US affiliate of the global Merz Pharma Group) received FDA clearance for the long-term improvement in the appearance of cellulite on the buttocks and thighs with no loss of...
The Cellfina System (Ulthera Inc., a subsidiary of Merz, Inc. and a US affiliate of the global Merz Pharma Group) received FDA clearance for the long-term improvement in the appearance of cellulite on the buttocks and thighs with no loss of...
The Cellfina System (Ulthera...
08/28/2015
The Dermatologist
Women May Pay More Than Men for Hair Loss Treatment
06/09/2017
Women may pay more than men at their local store for the same hair loss medicine, suggests a new study.
Women may pay more than men at their local store for the same hair loss medicine, suggests a new study.
Women may pay more than men at...
06/09/2017
The Dermatologist
Resident Journal Club
First Reports for Isotretinoin, Psoriasis and PUPPP
02/24/2015
This online-only feature is an ongoing review of past peer reveiw journal articles that have had a significant impact on dermatology. Sarah B. Koch, MD First Uses of Isotretinoin For Acne The treatment of acne with the oral derivative of...
This online-only feature is an ongoing review of past peer reveiw journal articles that have had a significant impact on dermatology. Sarah B. Koch, MD First Uses of Isotretinoin For Acne The treatment of acne with the oral derivative of...
This online-only feature is an...
02/24/2015
The Dermatologist
Discussions With HCPs, Nonsurgical Cosmetic Options, & Documenting Treatment
05/05/2017
Section Editor, Benjamin Barankin, MD, FRCPC
Clinical tips to help better your practice.
Clinical tips to help better your practice.
Clinical tips to help better...
05/05/2017
The Dermatologist
Phase III Ixekizumab Studies Results Released
08/26/2014
Investigational medicine ixekizumab (Eli Lilly and Company) was statistically superior to etanercept and placebo on all skin clearance measures in Phase III studies, according to the company. Results from its pivotal UNCOVER studies in...
Investigational medicine ixekizumab (Eli Lilly and Company) was statistically superior to etanercept and placebo on all skin clearance measures in Phase III studies, according to the company. Results from its pivotal UNCOVER studies in...
Investigational medicine...
08/26/2014
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
Riya Gandhi, MA, Associate Editor
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA, Associate Editor
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA, Associate Editor
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA, Associate Editor
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
Jessica Garlewicz, Digital Managing Editor
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use